Author:
de Labriolle Axel,Genée Olivier,Heggs Laurens Mitchell,Fauchier Laurent
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Toxicology,Molecular Biology
Reference10 articles.
1. de Groot, A. N., van Dongen, P. W., Vree, T. B., Hekster, Y. A., & van Roosmalen, J. (1998). Ergot alkaloids: Current status and review of clinical pharmacology and therapeutic use compared with other oxytocics in obstetrics and gynaecology. Drugs, 56, 523–535. doi: 10.2165/00003495-199856040-00002 .
2. Lange, R. A., & Hillis, L. D. (1994). Assessment of cardiovascular function. In C. J. Pepine, J. A. Hill, & C. R. Lambert (Eds.), Diagnostic and therapeutic cardiac catheterization (2nd ed., pp. 394–429). Baltimore: Williams & Wilkins.
3. Lin, Y. H., Seow, K. M., Hwang, J. L., & Chen, H. H. (2005). Myocardial infarction and mortality caused by methylergonovine. Acta Obstetricia et Gynecologica Scandinavica, 84, 1022. doi: 10.1111/j.0001-6349.2005.0058d.x .
4. Taylor, G., & Cohen, B. (1985). Ergonovine-induced coronary artery spasm and myocardial infarction after normal delivery. Obstetrics and Gynecology, 66, 821–822.
5. Liao, J., Cockrill, B., & Yurchak, P. (1991). Acute myocardial infarction after ergonovine administration for uterine bleeding. The American Journal of Cardiology, 68, 823–824. doi: 10.1016/0002-9149(91)90669-C .
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献